| 000 | 00643nam a2200181 ib4500 | ||
|---|---|---|---|
| 001 | D0001J001543 | ||
| 003 | DOH | ||
| 005 | 20241007134748.0 | ||
| 008 | 241007t ||||| |||| 00| 0 eng d | ||
| 100 | 1 | _aYates, Tom A. | |
| 245 | 0 | 0 |
_aDrug-resistant tuberculosis treatments, the case for a phase III platform trial / _cBy: Tom A. Yates [and eleven others] |
| 580 | _aBulletin of the World Health Organization 2024 102(9) 657-664 | ||
| 650 | 0 | 2 |
_aAntitubercular Agents _vtherapeutic use |
| 650 | 0 | 2 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 2 | _aDiarylquinolines |
| 650 | 0 | 2 |
_aTuberculosis, Multidrug-Resistant _vdrug therapy |
| 942 | _cJA | ||
| 999 |
_c6660 _d6660 |
||